Jade Biosciences (JBIO) Misses Q2 EPS by 11c

Jade Biosciences (NASDAQ: JBIO) reported Q2 EPS of ($0.76), $0.11 worse than the analyst estimate of ($0.65).

For earnings history and earnings-related data on Jade Biosciences (JBIO) click here.

You May Also Be Interested In

• DA Davidson Reiterates Buy Rating on Oracle (ORCL) Following Q1 Print
• Kroger (KR) Tops Q2 EPS by 3c, Misses on Revenue; Offers FY27 EPS Guidance
• SEALSQ posts 131% revenue gain in H1 2026, net loss widens